APOHEALTH DESLORATADINE desloratadine 5 mg tablet blister pack (new formulation)

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

desloratadine, Quantity: 5 mg

MAH:

Arrotex Pharmaceuticals Pty Ltd

pharmaceutical_form:

Tablet, film coated

composition:

Excipient Ingredients: dibasic sodium phosphate; lactose monohydrate; pregelatinised starch; magnesium stearate; maize starch; colloidal anhydrous silica; microcrystalline cellulose; hydrogenated cottonseed oil; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin; indigo carmine aluminium lake

administration_route:

Oral

units_in_package:

5, 3, 14, 42, 60, 2, 15, 50, 30, 10, 25, 28, 40, 45, 20, 7

prescription_type:

(S2) Pharmacy Medicine

therapeutic_indication:

The rapid relief of symptoms associated with seasonal allergic rhinitis. The nasal symptoms of allergic rhinits include rhinorrhoea, sneezing and nasal itching. Allergic rhinitis is also associated with non-nasal symptoms such as ocular itching, tearing and itching of the eyes or palate. The relief of symptoms associated with perennial allergic rhinitis. The symptomatic relief of itching and reduction in the size and number of hives associated with chronic idiopathic urticaria.

leaflet_short:

Visual Identification: Blue, round, biconvex tablets; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

authorization_status:

Registered

authorization_date:

2022-03-16